Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Philadelphia-Camden-Wilmington, PA-NJ-DE-MD MSA — October 2026
Philadelphia life sciences pay climbs while broader metro jobs stall.
Metro Regulatory Affairs Specialist pay rose to $112,763 even as national pay for the role fell to $103,780, while Philadelphia's overall employment held flat against national job growth.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro Regulatory Affairs pay: $112,763 — vs national $103,780, down moderately
- PA life sciences job postings: +213% YoY — Through August 2026, per Life Sciences Pennsylvania
- Metro unemployment rate: 4.1% — June 2026, vs 4.2% U.S. rate
- Captive manufacturing investment: $800M + Lilly facility — GSK expansion plus new Lehigh Valley site, ~1,150 jobs
Key takeaways
Regulatory affairs pay is diverging from the national trend.
Metro median advertised pay for Regulatory Affairs Specialists rose to $112,763 while the national figure fell to $103,780 — a reversal that suggests Philadelphia employers are bidding up scarce compliance talent even as national demand softens. Compensation strategies anchored to national data risk underpricing this role locally.
Clinical Research Associate pay gap signals a sourcing decision, not just a pay gap.
Metro CRA median pay of $69,000 trails the national median of $90,065 by roughly 23%, even as national demand for experienced CRAs remains candidate-driven. That spread may reflect heavier local reliance on CRO staffing models rather than direct hires, worth confirming before assuming the metro is simply underpaying.
Captive manufacturing investment is reshaping the build-vs-outsource calculus.
GSK's $800M expansion and Eli Lilly's Lehigh Valley facility both favor in-house capacity over CDMO reliance, adding roughly 1,150 combined jobs to a region already short on biomanufacturing and automation engineering talent. Leaders weighing outsourcing decisions should expect intensifying competition for the same credentialed workforce these projects are chasing.
Executive-level scarcity is becoming the binding constraint, not entry-level supply.
Life Sciences Pennsylvania leadership has flagged a shortage of executive talent to lead companies and attract capital, even as overall postings surged 213% year-over-year. Succession and retention planning at the VP and C-suite level may deserve more attention than volume hiring metrics suggest.
Median advertised pay by role — Philadelphia-Camden-Wilmington, PA-NJ-DE-MD MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $93,949 | $129,162 | $141,872 | Significant increase | $130,339 |
| Clinical Research Associate | $59,228 | $69,000 | $89,828 | Moderate increase | $90,065 |
| Lab Technician | $40,114 | $52,000 | $58,831 | Stable | $47,840 |
| Regulatory Affairs Specialist | $80,721 | $112,763 | $120,010 | Significant increase | $103,780 |
| Clinical Data Manager | $97,692 | $122,695 | $160,036 | Stable | $123,653 |
| Biostatistician | $100,802 | $135,000 | $149,877 | Moderate decline | $131,958 |
| Validation Engineer | $88,995 | $106,532 | $122,182 | Stable | $106,478 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Philadelphia metro employment has held roughly flat over the past year even as the nation added jobs, but life sciences is defying that stall — GSK's $800M Upper Merion expansion and Eli Lilly's planned Lehigh Valley injectable facility signal captive manufacturing buildouts rather than retrenchment. Pennsylvania life sciences job postings rose 213% year-over-year through August, yet experienced regulatory, clinical, and biomanufacturing talent remains scarce enough that advertised pay for Regulatory Affairs Specialists in the metro climbed to a median of $112,763, well above the declining national figure of $103,780.
What it means
Metro-level Research Scientist and Regulatory Affairs Specialist pay is outpacing national medians even as overall Philadelphia employment stagnates, indicating life sciences employers are competing against each other for a fixed regional talent pool rather than drawing from broader metro labor slack. GSK and Lilly's capital commitments point toward build-over-outsource strategies that will intensify competition for clinical operations, quality, and automation engineering talent already stretched thin at CSL and Sanofi's local sites. Organizations should evaluate whether regulatory affairs and clinical data roles are priced against current metro advertised rates rather than last year's survey cycle, given the gap between local and national trajectories.
Looking ahead
Expected: BLS metro-level unemployment data for October won't publish until mid-to-late November; watch whether the 4.1% June reading has moved materially once released, particularly given the metro's flat employment trend against national growth.
Emerging pressure point: CSL King of Prussia and Sanofi Swiftwater are simultaneously recruiting for senior clinical trial, biostatistics, and GMP/GCLP compliance roles — concentrated competition for the same skill sets could accelerate counteroffers and advertised pay movement over the next quarter.
Worth watching: Comcast Technology Center's WARN filing for 634 workers effective December 31 is outside life sciences, but watch whether displaced technical and compliance-adjacent talent migrates into biotech/pharma data and quality functions, easing some local scarcity.
Potential inflection point: Eli Lilly's Lehigh Valley facility targets 850 roles by 2031 — early site hiring activity over the next two months will signal how aggressively pharma employers plan to compete for automation and manufacturing engineering talent against GSK's concurrent expansion.
Sources
- Life Sciences Pennsylvania / GSK announcement — GSK $800M expansion and 300+ new PA jobs over five years
- Life Sciences Pennsylvania — PA life sciences job postings rose 213% year-over-year through August
- Eli Lilly corporate announcement — Eli Lilly Lehigh Valley facility targeting 850 jobs by 2031
- Bureau of Labor Statistics — Philadelphia metro unemployment rate 4.1% in June 2026
- Life sciences industry workforce survey — Experienced CRAs are the hiring bottleneck nationally, not entry-level talent
- Pennsylvania WARN Act notices — Comcast Technology Center WARN notice for 634 workers effective Dec. 31, 2026
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.